Channel
@Epsa_News
On this record: Growth · Engagement · Reactions · Posts · Citations · Cite this entry
253subscribers
+3 since we began measuring on 23 August 2026
Risers and fallers across the register · movement among entries of Under 1,000.
| Telegram ID | -1003868847604 |
|---|---|
| Type | Channel |
| Username | @Epsa_News |
| Created | Between 1 February 2026 and 9 July 2026 — estimated from Telegram’s id allocation, not measured. How this range is calculated. |
| First recorded | 23 August 2026 |
| Last confirmed live | 16 September 2026 |
| Measurements held | 5 |
| Confirmed unchanged | 1 time, most recently 16 September 2026 |
| On Telegram | t.me/Epsa_News |
| Measured (UTC) | Subscribers | Change |
|---|---|---|
| 16 Sept 2026, 18:15 | 253 | +1 |
| 9 Sept 2026, 10:56 | 252 | -1 |
| 1 Sept 2026, 04:05 | 253 | +2 |
| 24 Aug 2026, 07:46 | 251 | +1 |
| 23 Aug 2026, 03:30 | 250 | first reading |
14 posts held, back to 9 July 2026 — the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 1 page of Telegram’s post history, 20 posts per page.
Nothing published in the last 30 days. ERR and ER are rolling 30-day measures, so there is nothing to compute — we hold 14 posts for this entry, the most recent from 9 August 2026. An engagement rate over an empty window would be a number about nothing.
19 reactions across 10 posts, in 4 distinct kinds. The most used accounts for 36.8% of them.
| Reaction | Count | Share | Share, drawn |
|---|---|---|---|
| 👍 | 7 | 36.8% | |
| ❤ | 6 | 31.6% | |
| 👀 | 3 | 15.8% | |
| 👏 | 3 | 15.8% |
No sentiment is inferred, and none should be read in. This table is ordered by count and by nothing else. Emoji do not carry stable meaning across languages or communities — 🙏 is thanks in one channel and mourning in another — so we publish which ones were pressed and how often, and pass no judgement on what an audience meant by them.
Precision. Telegram publishes reaction counts per emoji and short-forms each one — 4.34K, 1.2M — so any single kind at or above 1,000 reaches us at three significant figures, and only counts below 1,000 are exact. The shares above are ratios of those figures and carry the same error. This is also why the total here can differ slightly from a reaction total printed elsewhere on the page: both are sums of the same rounded parts, taken over samples with different edges.
Coverage. Reactions were read on 10 of the 14 sampled posts in this sample. Summed by Telegram’s own count on each post — not by adding up the per-emoji breakdown above — those same posts carry 19 reactions in total: the kind of figure the paragraph above means by “a reaction total printed elsewhere on the page”.
Measured over the 14 most recent posts we hold, published 9 July 2026 to 9 August 2026, using the newest reading held for each. Telegram Stars are excluded: they are a payment, not a reaction, and they have their own section.
🧬 FDA Approves New Gene Therapy Combination for Advanced Melanoma The U.S. FDA has granted accelerated approval to Tudriqev (vusolimogene oderparepvec) in combination with nivolumab for adults with unresectable or metastatic melanoma that has progressed after prior treatment. Tudriqev is an oncolytic immunotherapy designed to infect tumor cells and stimulate an immune response against cancer. 📌 Why it matters: The…
🦠 New Antimicrobial Peptide Licensed to Support AMR Research Qnovia has licensed a novel antimicrobial peptide for further development as a potential treatment for drug-resistant bacterial infections. The candidate is being investigated as part of ongoing efforts to address the growing global challenge of antimicrobial resistance (AMR). 📌 Why it matters: With antimicrobial resistance continuing to threaten the effe…
❤1
🤖 Ethiopia Opens Robotic Surgery Training Hubs for Africa Ethiopia has launched the China–Africa Robotic Surgery Training Center and the China–Africa Endoscopic Technology Training Center in Addis Ababa, where more than 30 surgeons from across Africa have begun training in robotic and minimally invasive surgery. 📌 Why it matters: The new centers aim to strengthen surgical skills, expand access to advanced surgical …
❤3
🧪 WHO Lists First Diagnostic Test for Bundibugyo Ebola Virus The World Health Organization (WHO) has added the first molecular diagnostic test for the Bundibugyo strain of Ebola virus to its Emergency Use Listing (EUL). The test enables rapid detection of the virus by identifying its genetic material in blood samples. 📌 Why it matters: Faster and more accurate diagnosis is essential for early case detection, timely…
🚨 Cyclophosphamide Injection Recalled Over Particulate Matter Long Grove Pharmaceuticals has voluntarily recalled one lot of Cyclophosphamide for Injection after the presence of steel particulate matter was identified in the product. 📌 Why it matters: Particulate contamination in injectable medicines may pose serious health risks, highlighting the importance of strict quality control in sterile pharmaceutical manuf…
👍2
🚨 Cetirizine Tablets Recalled Nationwide Due to Potential Cross-Contamination Unique Pharmaceutical Laboratories has voluntarily recalled certain Cetirizine Hydrochloride Tablets USP 5 mg after discovering the potential for cross-contamination with ranitidine during manufacturing. 📌 Why it matters: The recall highlights the importance of manufacturing quality control and protecting patients from unintended contamin…
❤1
🎗️ EMA Begins Review of New Pancreatic Cancer Medicine The European Medicines Agency (EMA) has started a rolling review of a new investigational medicine for metastatic pancreatic cancer, aiming to accelerate its evaluation due to the high unmet medical need associated with this aggressive cancer. 📌 Why it matters: Pancreatic cancer has limited effective treatment options, and faster regulatory review could help br…
👍2
💉 Ethiopia Strengthens Polio Prevention Along South Sudan Border Ethiopia and South Sudan have conducted a synchronized polio vaccination campaign targeting over one million children under five in high-risk border areas and refugee communities. The campaign followed detection of circulating vaccine-derived poliovirus type 1 (cVDPV1) in South Sudan, raising concerns about cross-border transmission. 📌 Why it matters…
💊 FDA Approves First Oral PCSK9 Inhibitor for High Cholesterol The U.S. FDA has approved Lipfendra (enlicitide), the first oral PCSK9 inhibitor for adults with hypercholesterolemia who require additional LDL-cholesterol lowering despite standard therapy. Unlike existing PCSK9 inhibitors, which are administered by injection, Lipfendra is taken as a once-daily tablet. 📌 Why it matters: The approval offers a more con…
🚨 WHO Warns of Falsified DARZALEX Cancer Medicine The World Health Organization (WHO) has issued a medical product alert after identifying falsified batches of DARZALEX (daratumumab), a medicine used to treat multiple myeloma and AL amyloidosis. The counterfeit products were detected in Mexico and the Maldives and were supplied through unauthorized distributors. 📌 Why it matters: Falsified medicines can put patien…
👍1
Pharmacure Pharmaceuticals Manufacturing PLC has launched seven (7) of the first locally produced pediatric Intravenous (IV) infusion products today, 14 July 2026, at the Pharmaceutical Factory premises. The event began with a welcoming speech by Mr. Solomon G/Amanuel, the Factory General Manager. The launching ceremony was officially opened by H.E. Mrs. Frehiwot Abebe, State Minister at the FDRE Ministry of Health.…
👏3❤1
💉 FDA Approves Subcutaneous Version of Sarclisa for Multiple Myeloma The U.S. FDA has approved Sarclisa Escena, a subcutaneous formulation of Sanofi's multiple myeloma treatment Sarclisa (isatuximab-irfc). It is the first subcutaneous anticancer therapy that can be administered either manually or using an on-body injector. 📌 Why it matters: The new formulation offers a more convenient administration option while ma…
👍1
Showing the 12 most recent of 14 posts we hold for @Epsa_News. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked ≈ was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.
Republished by
Channels on the register that have forwarded this channel's posts into their own feed.
Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.
A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 16 September 2026 — this entry's latest reading, not the date you are reading this.
“EPSA Newsletter📰🗞” (@Epsa_News), 253 subscribers as measured 16 September 2026. Telegram Register, tgregister.com/channel/Epsa_News.
Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.